Cargando…
Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7
Epigenetic gene silencing by aberrant DNA methylation leads to loss of key cellular pathways in tumorigenesis. In order to analyze the effects of DNA methylation on prostate cancer, we established LNCaP-derived human prostate cancer cells that can pharmacologically induce global reactivation of hype...
Autores principales: | Miyauchi, Toshiya, Takahashi, Masahiro, Mitsuzuka, Koji, Saiki, Yuriko, Okubo, Teppei, Vertino, Paula M., Goto, Akiteru, Arai, Yoichi, Horii, Akira, Fukushige, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881737/ https://www.ncbi.nlm.nih.gov/pubmed/33628338 http://dx.doi.org/10.1155/2021/8858905 |
Ejemplares similares
-
Targeted TET oxidase activity through methyl‐CpG‐binding domain extensively suppresses cancer cell proliferation
por: Mizuguchi, Yasuhiko, et al.
Publicado: (2016) -
TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study
por: Fujiwara, Sho, et al.
Publicado: (2023) -
High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma
por: Liang, Aijun, et al.
Publicado: (2021) -
The Inflammatory Gene PYCARD of the Entorhinal Cortex as an Early Diagnostic Target for Alzheimer’s Disease
por: Liu, Wenjia, et al.
Publicado: (2023) -
CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer
por: Qin, Xiao-Ping, et al.
Publicado: (2022)